Venezuela is a singular case, as we've discussed previously. The inflation rate is 140%, and foreign companies cannot withdraw any money from their Venezuelan subsidiaries.
ABT addendum: The 9.5% YoY growth in branded-generic drugs included Venezuela; excluding Venezuela, 2Q16 sales of branded generics increased 14% YoY in constant currency.